Cargando…
Reversible Contraceptive Potential of FDA Approved Excipient N, N-Dimethylacetamide in Male Rats
Development of an effective male contraceptive agent remains a challenge. The present study evaluates the potential of N, N-Dimethylacetamide (DMA), a FDA approved excipient as a male contraceptive agent. Male Sprague Dawley rats injected with DMA for a period of 8 weeks (one injection per week) sho...
Autores principales: | Khera, Nupur, Ghayor, Chafik, Lindholm, Anna K., Pavlova, Ekaterina, Atanassova, Nina, Weber, Franz E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683412/ https://www.ncbi.nlm.nih.gov/pubmed/33240111 http://dx.doi.org/10.3389/fphys.2020.601084 |
Ejemplares similares
-
N,N Dimethylacetamide a drug excipient that acts as bromodomain ligand for osteoporosis treatment
por: Ghayor, Chafik, et al.
Publicado: (2017) -
The Release of the Bromodomain Ligand N,N-Dimethylacetamide Adds Bioactivity to a Resorbable Guided Bone Regeneration Membrane in a Rabbit Calvarial Defect Model
por: Siegenthaler, Barbara, et al.
Publicado: (2020) -
Effect of N-Vinyl-2-Pyrrolidone (NVP), a Bromodomain-Binding Small Chemical, on Osteoblast and Osteoclast Differentiation and Its Potential Application for Bone Regeneration
por: Klemmer, Viviane A., et al.
Publicado: (2021) -
2-Cyano-N,N-dimethylacetamide
por: Liu, Shan, et al.
Publicado: (2012) -
Urea–N,N-dimethylacetamide (1/1)
por: Fernandes, Philippe, et al.
Publicado: (2008)